Despite the smoking stigma associated with lung cancer, one in five lung cancer patients have never smoked.
On average, people diagnosed with lung cancer have less than a one-in-five chance of surviving five years after being diagnosed. With such a significant burden, the need to better understand this disease and find more effective therapies is critical.
Lung Cancer Support
This blood test aims to determine if the patient’s treatment has been effective or whether the cancer has returned, without the need for performing invasive biopsies.
Researcher
Dr Anand Rose hopes the test will somewhat ease patients’ journeys as they battle this deadly disease.
Investigating a newly-discovered chemical compound treatment which has shown promise in inhibiting the growth of lung cancer cells.
Researcher
Dr Joanna Woodcock is also looking at innovative ways to deliver the treatment directly to the cancer cells, such as through inhalable forms like a puffer!
Researching the role of cellular 14-3-3 proteins in non-small cell lung cancers (NSCLC), with the aim of finding new treatment options to improve survival rates.
Researcher
Rhys Hammon says cellular 14-3-3 proteins are more abundant in 50-60% of non-small cell lung cancers (NSCLC), and increase resistance to treatments and lead to poor prognosis.
